Serum from a patient with GAD65 antibody-associated limbic encephalitis did not alter GABAergic neurotransmission in cultured hippocampal networks
Background: Glutamate decarboxylase (GAD) is an intracellular enzyme converting glutamate into GABA. Antibodies (ab) to its isoform GAD65 were described in limbic encephalitis (LE) and other neurological conditions. The significance of GAD65-ab for epilepsy is unclear, but alterations of inhibitory...
Main Authors: | Nelly eStemmler, Karin eRohleder, Michael eMalter, Guido eWidman, Christian E Elger, Heinz eBeck, Rainer eSurges |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00189/full |
Similar Items
-
Treating a GAD65 antibody-associated limbic encephalitis with Basiliximab, a case study
by: Guido eWidman, et al.
Published: (2015-08-01) -
Epileptic Activity in a Patient with Serum Anti-GAD Antibody-positive Limbic Encephalitis
by: Zeynep ÖZÖZEN AYAS, et al.
Published: (2020-04-01) -
Histopathologic Characterization and Neurodegenerative Markers in Patients With Limbic Encephalitis Undergoing Epilepsy Surgery
by: Attila Rácz, et al.
Published: (2022-04-01) -
Anti-GAD-associated limbic encephalitis: an unusual clinical manifestation from northwest of Ireland
by: Salman Mansoor, et al.
Published: (2020-02-01) -
Spontaneous and evoked neurotransmission are partially segregated at inhibitory synapses
by: Patricia M Horvath, et al.
Published: (2020-05-01)